产品编号 :
Cas No. :
CAS No. |
1175077-25-4 |
|---|---|
中文名称 |
LYG-202(研发代号,缺少可解析的IUPAC系统命名信息) |
英文名称 |
LYG-202 |
别名 |
5-Hydroxy-8-methoxy-7-[4-(4-methyl-1-piperazinyl)butoxy]-2-phenyl-4H-1-benzopyran-4-one;LYG-202;4H-1-Benzopyran-4-one, 5-hydroxy-8-methoxy-7-[4-(4-methyl-1-piperazinyl)butoxy]-2-phenyl-;LYG202|||LYG 202 |
标准英文名 |
5-hydroxy-8-methoxy-7-(4-(4-methylpiperazin-1-yl)butoxy)-2-phenyl-4H-chromen-4-one |
MDL No. |
MFCD26793880 |
分子式 |
C25H30N2O5 |
分子量 |
438.52 |
精确分子量 |
438.22 |
SMILES |
O=C1C=C(C2=CC=CC=C2)OC3=C1C(O)=CC(OCCCCN4CCN(C)CC4)=C3OC |
标准SMILES |
CN1CCN(CCCCOC2C=C(O)C3C(=O)C=C(OC=3C=2OC)C2C=CC=CC=2)CC1 |
用途 |
LYG-202 exhibits potent anti-angiogenic and anti-tumor activities; it inhibits VEGF-stimulated migration and tube formation of HUVECs; it induces apoptosis in cancer cells. |
InChIKey |
ICGYSEWPMDWBIL-UHFFFAOYSA-N |
|
|
评论 |
|---|